当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Thomas E Terndrup
Transplanting a head and brain is probably the ultimate frontier of organ transplantation. The goal of body- to- head transplantation (BHT) is to sustain the lifetime of individualities that suffer from terminal grievance, however whose head and brain square measure healthy. Ideally BHT might provide a delivery treatment for many conditions wherever none presently exists.BHT isn't any standard trial, to transfer a head to a different body involves terribly advanced medical challenges moreover as moral and empirical dilemmas that were preliminarily confined to the imagination of pens of fabrication.The likelihood of commutation associate degree incurably sick body with a healthy bone tests not solely our surgical limits, however additionally the social and cerebral boundaries of physical life and alters what we have a tendency to fete life to be [1].The purpose of this target composition, the reciprocal handwriting focused on immunologic problems in BHT, and also the incidental to narrative by students and interpreters in drug, immunology, and ethics is to review major surgical and psychosocial-ethical and immunologic concerns girding body- to- head transplantation. we have a tendency to hope that along these ideas can provide compendiums with a comprehensive summary of the probabilities and challenges related to BHT and initiate skilled discussion and dialogue through that this new frontier in drug is taken into account and approached [2].